上海多米瑞生物技术有限公司 Reviews, Salaries and Jobs

Company Overview

Nature: 国企 Size: 少于50人 Founded: 11年
Industry: 制药/生物工程、学术/科研
Full name: 上海多米瑞生物技术有限公司。

Development Stage

Ranking: Ranked #5 in Shanghai蛋白质药物公司 by popularity Ranked #9 in Shanghai产学研合作公司 by popularity Ranked #10 in Shanghai溯源技术公司 by popularity Ranked #10 in Shanghai制药原料公司 by popularity
Honors: 科技型中小企业市级专精特新中小企业 According to algorithm
Salary: 84.6% of positions earn 8-15K, In 2026 vs last yeardecreased by 18%.。Master's salary: ¥10.2K.
Recruiting: In 2026 vs 2025grew by 300%.
Requirement: Education: 本科 leads with 69.2%. Experience: 应届生 leads with 34.6%.
Region: Distributed across 1 regions, 上海: 100%.

About the Company

上海多米瑞生物技术有限公司扎根上海张江、临港生物医药核心片区，聚焦多肽与重组蛋白药物细分领域的“生物类似药 + 原创新药”双轮驱动型央企研发平台‌。溯源1957年上海医药工业研究院多肽科研课题组，2015年正式改制成立，是国药集团医工总院核心产业化落地平台。公司汇聚资深科研团队，深耕多肽合成、重组蛋白表达、微生物提取三大核心技术，构建从分子设计、工艺开发、中试放大、质量研究到注册申报、产业转化的全链条研发体系，具备成熟的创新药与高端生物类似药研发落地能力。

Expand

Information is aggregated from the web and may not be exact. For reference only.

Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (6 open positions)

Manage

Growth Rate

2026 vs 2025

2025: Up 67%
2024: Down 50%

Year-by-Year Hiring:

2021 5 jobs 2023 6 jobs 2024 3 jobs 2025 5 jobs 2026 ? *** 

* Hiring was generally low during 2020-2022 due to the pandemic

Shanghai 8

Campus Recruitment & Advanced Degree Talent Demand

Graduates 1

No.986

Graduate Talent Ranking in Shanghai 򀀩

Latest Jobs

Note: How fast is hiring at 上海多米瑞生物技术有限公司 growing? 2025: 5 openings (up 67%), 2024: 3 openings (down 50%), 2023: 6 openings, 2021: 5 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)

+400%

Growth Rate

2026 vs 2025

Master's Hiring by Year: 2026 — 4 more jobs than 2025

2021 2 jobs 2025 1 jobs 2026 5 jobs

* Hiring was generally low during 2020-2022 due to the pandemic

N/A

Master's Salary 򀀩

How fast is master's hiring at 上海多米瑞生物技术有限公司 growing? Master's recruitment over the years: 2026: 5 openings (up 300%), 2025: 1 openings (up 67%), 2021: 2 openings.

— What Are the Salaries Like? (26 records)

Manage

Salary Overview

salary range: 6K - 30K, 84.6% of roles pay ￥8-15K

7.7% 6-8K ***  ? 8-10K ***  ? 10-15K 3.8% 15-20K 3.8% 20-30K

Note: salary statistics are based on 26 salary records from the past year and depend on the job sample. For reference only.

Salary Ranking

By Category

工厂生产类￥12.8K  生物/制药/化工/环保类  质量管理类  技工类  科研类 

How is the salary at 上海多米瑞生物技术有限公司?84.6% of positions earn 8-15K, Fresh graduate salary: ¥9.4K。工厂生产类 average salary ¥12.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)

Are salaries high at 上海多米瑞生物技术有限公司? We provide: 生产工，研究员，qc，供应链，仓库，库管，qa，分析，制剂研究，办公室助理，生化主管，科研助理，行政助理，高级专员. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

工厂生产类
46.2% of total 46.2%
生物/制药/化工/环保类
34.6% of total 34.6%
质量管理类
34.6% of total 34.6%
技工类
26.9% of total 26.9%

Job Location

上海
100% of total 100%

Education

本科
69.2% of total 69.2%
硕士
23.1% of total 23.1%
大专
7.7% of total 7.7%

Experience

应届生
34.6% of total 34.6%
3-5年
34.6% of total 34.6%
1-3年
26.9% of total 26.9%
不限
3.8% of total 3.8%

View Detailed Analysis

What does 上海多米瑞生物技术有限公司 require? Who is 上海多米瑞生物技术有限公司 hiring? recruitment: 工厂生产类占比最多占46.2%，其次是生物/制药/化工/环保类占34.6%. What education can get in at ? 本科占比最多占69.2%，其次是硕士占23.1%. High education required at ? 硕士占23.1%. Work experience required at ? 应届生占比最多占34.6%，其次是3-5年占34.6%. Where are the job locations at ? 上海占比最多占100%. Based on job postings from the past year, for reference only.